TABLE 3.
Concentrations of the quantified retinoids in serum from 20 healthy men
Analyte | Mean ± SD(nM) | Minimum(nM) | Median(nM) | Maximum(nM) | Wilcoxon Signed-Rank TestFed vs. Fast P value |
atRA | |||||
Fed | 3.1 ± 0.9 | 1.7 | 2.9 | 5.2 | 0.82 |
Fasted | 3.0 ± 0.6 | 1.9 | 3.1 | 4.4 | |
13-cisRA | |||||
Fed | 5.3 ± 5.7 | 2.4 | 3.9 | 29.0 | 0.27 |
Fasted | 3.9 ± 1.0 | 2.7 | 3.8 | 7.3 | |
9-cisRA | |||||
Fed | 0.1 ± 0.1 | 0.05 | 0.09 | 0.49 | 0.14 |
Fasted | 0.08 ± 0.02 | 0.05 | 0.09 | 0.15 | |
9,13-dicisRA | |||||
Fed | 0.4 ± 0.4 | 0.1 | 0.3 | 1.8 | 0.09 |
Fasted | 0.3 ± 0.1 | 0.1 | 0.2 | 0.7 | |
4oxo-13cisRA | |||||
Fed | 17.8 ± 31 | 7.1 | 10.2 | 146 | 0.59 |
Fasted | 12.2 ± 7.2 | 6.8 | 10.7 | 40.4 |